Natural Health Trends Corp. (NHTC) Stock Price & How to Invest

Last updated November 2026

Short answer

Natural Health Trends (NHTC) is a tiny Nasdaq-listed direct seller of wellness and personal care products whose sales come mostly from Hong Kong and mainland Chinese members. At ~$0.68 on November 20, 2026 the company is valued at ~$5.8M while holding ~$17.6M of cash, so the market is pricing in continued shrinkage and cash burn rather than a recovery. It is a deep-value, high-risk situation, not a growth story.

NHTC stock price

As of 2026-11-20, Natural Health Trends Corp. (NHTC) last closed at $0.6400, down 77.7% over the past year. Over the past 52 weeks it has traded between $0.6400 and $4.00.

NHTC last close
$0.6400
1 day
-3.03%
1 month
-24.71%
1 year
-77.70%
52-week range
$0.6400 to $4.00
Last close
2026-11-20

Prices are daily closing prices from Yahoo Finance and may be delayed. For the live quote, check your broker or Natural Health Trends Corp.'s investor relations page. Walnut is informational, not investment advice.

NHTC key stats

At $0.64 on November 20, 2026, Natural Health Trends Corp. (NHTC) has a market cap of $5M and a dividend yield of 62.50%.

Market cap
$5M
Price to book
0.4
Dividend yield
62.50%
Beta
1.02

Market cap, P/E and yield are measured at the $0.64 price on November 20, 2026, from Yahoo Finance figures pulled in November 2026. Earnings date from Yahoo Finance. Walnut is informational, not investment advice.

The last two weeks for Natural Health Trends Corp., as of November 22, 2026: the price move, the next earnings date, and what analysts changed.

  • NHTC closed at $0.64 on November 20, 2026, down 14.7% over the past five trading days (from $0.75).

Prices are daily closes from Yahoo Finance. Analyst actions come from Yahoo Finance as of November 2026. Walnut is informational, not investment advice.

Natural Health Trends Corp. sells nutritional supplements, personal care, wellness and lifestyle products under the NHT Global brand through a network of independent members, a model usually called direct selling or multi-level marketing. The company is incorporated in Delaware with US offices in California, but its business is overwhelmingly Asian: Hong Kong is the hub through which most orders flow, and many of those buyers are members in mainland China, where the company does not run a licensed direct-selling operation and instead relies on a cross-border e-commerce setup. Smaller markets include Taiwan, South Korea, Japan, Peru and parts of Europe and North America. Gross margins are high, ~75%, which is typical for the industry, but the commission payouts to members absorb a large share of that.

The last two years have been a steady contraction. Revenue fell from ~$42.9M in 2024 to ~$39.8M in 2025, and then slid faster in 2026: ~$9.2M in Q1, ~$7.6M in Q2 (down ~23% year over year) and ~$7.6M in Q3 (down ~20%), reported on October 28, 2026. Active members dropped to ~26,000 at mid-2026 from ~29,260 a year earlier. Management blames cautious consumer spending in China, regulatory uncertainty, and disciplinary action against some members for code-of-conduct breaches. A restructuring that cut jobs and moved manufacturing closer to Asia has narrowed the losses: the Q3 2026 net loss was ~$232K, versus ~$451K in Q2.

The investment picture is dominated by the balance sheet and the share price. In February 2026 the company bought out the Broady family's ~25.5% stake for ~$5.9M ($2.00 per share), cutting the share count to ~8.6M. It also halved the quarterly dividend to $0.10. Cash and marketable securities fell from ~$28.9M at the end of 2025 to ~$17.6M at September 30, 2026, after that buyout, dividends and operating losses. The stock kept falling after the Q3 report despite better margins: it closed near ~$0.68 on November 20, 2026, down ~78% year to date and ~73% over a year, and it has traded below $1 since late September, which exposes it to Nasdaq's minimum bid price rule. At ~$5.8M market cap the shares sit at roughly a third of cash, a gap that reflects the market's doubts about how long the cash will last and whether shareholders will see it.

1. Stabilizing the Hong Kong and China business

Everything at NHTC depends on Greater China, which supplies the large majority of sales. Q3 2026 revenue of ~$7.6M was flat against Q2, the first quarter in a while without a sequential drop, after falling from ~$9.7M in Q4 2025. Management is using incentive campaigns, lower-priced product packages and a Hong Kong 25th anniversary program to lift member counts, which stood at ~26,000 at mid-2026. If quarterly revenue can hold around ~$7.5M to ~$8M rather than continuing to slide, the cost cuts already made bring the company close to operating breakeven. If China consumer sentiment stays weak, the contraction that took revenue down ~20% a year could simply continue.

2. Restructuring and cost discipline

Late in 2025 the company announced job cuts and a shift of manufacturing toward its core Asian markets, targeting ~$1.5M of annualized savings. The results are visible: gross margin rose to ~75.2% in Q2 2026 from ~73.9% a year earlier, savings reached more than ~$600K in the first half, and the operating loss shrank to ~$277K in Q3 from ~$643K in Q2. Operating cash use for the first nine months of 2026 was ~$3.3M versus ~$5.0M a year earlier. On a business with ~$34M of trailing revenue, every few hundred thousand dollars of overhead matters, and further savings would be the most direct way to stop the cash pile shrinking.

3. Capital returns and the cash cushion

NHTC has a long history of returning cash, paying $0.20 a quarter for years before halving the dividend to $0.10 in early 2026. In February it repurchased ~2.94M shares from the Broady family at $2.00, and in July the board resumed open-market buybacks with ~$15.8M still authorized. Purchases since then have been small (~85K shares for ~$84K). With ~$17.6M of cash and securities and no meaningful debt, the company holds roughly $2.05 of cash per share against a ~$0.68 stock price on November 20, 2026. How that cash is used, whether for buybacks, dividends, a tender offer or simply funding losses, is the single biggest factor in what existing holders end up with.

4. New products and digital tools

Management's stated priorities are product innovation and better digital tools for members. Upcoming launches include Move Prime, a product based on traditional Chinese medicine, and upgrades to the company's AI-powered member app. Direct sellers depend on a steady cadence of new products to give members something to sell and recruit around, and NHTC's historical hits such as its Premium Noni and ReStore lines have aged. New launches are unlikely to move revenue much within a single quarter, but a successful product could help stabilize members and orders. The risk is that marketing spend on launches lands while the underlying consumer remains cautious, adding cost without lifting sales.

The most immediate risk is the listing. NHTC has closed below $1 since late September 2026, reaching a 52-week low near ~$0.64 in November, and Nasdaq issues a deficiency notice after 30 consecutive business days under that level, followed by a 180-day window to regain compliance. Companies in that position often turn to a reverse split, and a delisting to the OTC market would reduce liquidity further. The business itself is concentrated: most sales come from Hong Kong orders tied to mainland Chinese buyers, so Chinese regulation of direct selling and cross-border e-commerce, currency moves, and consumer sentiment there can hit results quickly. Revenue has fallen ~20% a year in 2026 and members are declining, and the company has posted net losses for several consecutive quarters. Cash fell ~$11M in nine months, partly by choice (the Broady buyout and dividends) and partly from losses. Multi-level marketing also carries reputational and regulatory risk, including the member misconduct issues management cited. Finally, the stock is very thinly traded at a ~$5.8M market cap, so prices can swing sharply on small orders and wide bid-ask spreads.

Is NHTC a buy or a sell?

We give no verdict on Natural Health Trends Corp.. Both cases are real, which is why the question is contested at all, so here is the strongest version of each.

The case for buying. Stabilizing the Hong Kong and China business. Everything at NHTC depends on Greater China, which supplies the large majority of sales.

The case against. The most immediate risk is the listing.

Read the full bull and bear case on NHTC, including what would have to change to break either one. Walnut is not an investment adviser.

Market cap, P/E and dividend yield at today's price are in the NHTC key stats above. The business figures below come from Natural Health Trends Corp.'s reported results as of November 2026 and change when it next reports.

  • Revenue (TTM): ~$34M
  • Cash and securities: ~$17.6M
  • Gross margin: ~75%
  • Operating loss (9M 2026): ~$1.4M
  • Shares outstanding: ~8.6M
  • Q3 2026 revenue: ~$7.6M, down ~20% year over year; net loss ~$232K

As of November 2026: By conventional measures NHTC looks extraordinarily cheap: the market cap is roughly 0.17x trailing revenue and about a third of the cash and marketable securities on the balance sheet, which implies a negative enterprise value of roughly ~$12M. That discount exists because the company is losing money, revenue is shrinking ~20% a year, and investors are uncertain how much of the cash will ever reach shareholders. The halved dividend, the July buyback resumption and the narrowing Q3 loss are the data points that could close the gap, but the stock fell further after the October 28 report. Continued burn and a sub-$1 listing problem could widen it.

Large global direct sellers

Herbalife (HLF), Nu Skin (NUS) and USANA Health Sciences (USNA) sell supplements and personal care through independent distributors worldwide, with meaningful China and Asia exposure. They are hundreds of times larger than NHTC, have licensed China operations and deeper product pipelines, and set the benchmark for compensation plans that NHTC competes against for members.

Smaller US-listed wellness direct sellers

Nature's Sunshine (NATR), LifeVantage (LFVN) and Mannatech (MTEX) are the closest listed peers in size and model. Mannatech in particular is a micro-cap with a similar product mix and shrinking revenue. Comparing them shows how much of NHTC's decline is industry-wide versus specific to its China concentration.

Chinese and private direct sellers

Amway China, Infinitus (part of Lee Kum Kee), Perfect China and other licensed domestic operators compete directly for the same mainland consumers and members. They hold China direct-selling licenses, have local manufacturing and large marketing budgets, and are increasingly joined by social-commerce sellers on Douyin and WeChat that reach health buyers without a member network.

Other names that sit close to NHTC: same theme, named as a direct competitor, or held beside it in the same funds. Each entry says which. They are useful if you want to spread one thesis across several tickers.

There are three common ways to get NHTC exposure. Buy shares (or fractional shares) directly at any major broker. Hold an ETF that includes it, which spreads the position across many companies. Or build it into a focused thematic portfolio, so NHTC sits alongside other stocks that express the same thesis.

Walnut takes the portfolio route. Describe a thesis where NHTC fits (for example “AI infrastructure” or “dividend-growth large-caps”) and the AI proposes 5 to 6 constituents with target weights. You review the plan and fund it through your own broker when you're ready.

New to this? Start with how to invest in stocks, see how to analyze a stock with AI, or compare the best AI stock analyzers.

NHTC trades at about a third of its cash pile because revenue keeps falling and China demand is weak, and the stock slid further after third-quarter results, down ~78% in 2026. The cash cushion is real, but so are the sub-$1 listing risk and ongoing losses.

Whether NHTC is worth buying today depends more on your time horizon and what you already hold than on any single call. We walk through valuation, what would have to go right, and the risks in is NHTC a buy or a sell?, and where the stock could go from here in the NHTC stock forecast.

For income investors, whether NHTC pays a dividend and how the payout looks is covered in does NHTC pay a dividend? And to weigh NHTC against a peer, read the full side-by-side comparisons: NHTC vs OTLY and NHTC vs GIS.

Wondering how NHTC fits the portfolio you already own? Walnut is an AI investing app that connects your brokerage read-only and answers questions like that about your actual holdings: overlap, concentration, and how each position tracks the S&P 500. Compare the best AI portfolio analyzers or see the best AI investing apps in 2026.

Your questions about Natural Health Trends Corp.

Ask Walnut's AI anything about NHTC and see how it fits what you own.

FAQ

Why did NHTC stock fall below $1 in 2026?

+

No single event caused it. The stock fell ~78% in 2026 through November 20, from about $4 within the past year to under $1 by late September and ~$0.68 by November 20, as several pressures stacked up. It dropped again after the October 28 Q3 report even though gross margin improved and the loss narrowed. Revenue dropped ~23% year over year in Q2 and ~20% in Q3, active members declined, and the company kept reporting net losses. The quarterly dividend, long the main reason many investors owned the stock, was cut in half to $0.10 early in the year, removing a key support for the price. Cash also fell from ~$28.9M to ~$17.6M after the Broady family buyout, dividends and operating losses. Our research found no reverse split, bankruptcy filing, going-concern warning or acquisition offer behind the move; it reflects a shrinking business and fading income appeal.

Is NHTC at risk of being delisted from Nasdaq?

+

It faces a real listing compliance issue. Nasdaq requires a minimum closing bid of $1.00, and a company that trades below that for 30 consecutive business days typically receives a deficiency notice and then has 180 calendar days (sometimes extendable) to close at or above $1 for at least ten consecutive days. NHTC has traded below $1 since late September 2026, so a notice is likely if the price does not recover. Companies in this position commonly regain compliance through a reverse stock split, which reduces the share count without changing the company's value. The Yahoo Finance headlines through November 20, 2026 show no deficiency notice or reverse split announcement, but holders should watch the company's 8-K filings for one.

Does NHTC still pay a dividend?

+

NHTC paid $0.20 per quarter for several years, then cut the dividend in half to $0.10 per quarter beginning in early 2026 as part of a restructuring. Payments of $0.10 were made in February and May 2026. Since then the board's emphasis has shifted toward share repurchases, which it authorized to resume in July 2026 with ~$15.8M left under the program. Our research did not find a new dividend declaration accompanying the Q2 or Q3 2026 results, and future payouts are at the board's discretion. Dividend yields shown on some data sites (sometimes above 40%) are computed from older payments against today's depressed price and do not reflect a confirmed forward payout, so they overstate what holders can expect.

Why is NHTC's market cap lower than its cash?

+

At ~$0.68 a share on November 20, 2026 and ~8.6M shares, NHTC's market value is ~$5.8M, against ~$17.6M of cash, cash equivalents and marketable securities at September 30, 2026. That works out to roughly $2.05 of cash per share. The market applies a large discount for three reasons. First, the business is losing money and cash fell ~$11M in nine months, so investors assume the pile will keep shrinking. Second, some of the cash sits in Asian subsidiaries and supports operations, so not all of it is freely distributable. Third, there is no catalyst that forces the value out, such as a sale of the company or a liquidation. Net-cash micro-caps can stay at a discount for years if burn continues.

What happened with the Broady family shares?

+

In February 2026 NHTC agreed to repurchase all ~2,935,227 shares held by two irrevocable trusts of the George K. Broady family, about 25.5% of the shares outstanding. The price was $2.00 per share, ~$5.9M in total, paid from cash on hand and approved by a special committee of the board. Management described the purchase as a way to remove a large overhang, the risk that a big holder would sell into a thinly traded market. After closing, shares outstanding fell to ~8.58M and annual dividend requirements dropped by ~$1.2M. The deal lifted remaining holders' ownership share but also used about a fifth of the company's cash, which is one reason the balance sheet is smaller today.

How exposed is NHTC to China?

+

Very. The company's largest market by far is Hong Kong, and much of that business comes from members living in mainland China who buy through the Hong Kong e-commerce channel. Management has repeatedly tied weak results to cautious Chinese consumer spending and regulatory uncertainty. China tightly regulates direct selling and periodically cracks down on health product marketing, and NHTC does not run a licensed direct-selling business there. Any change in how Beijing treats cross-border wellness sales, a further slowdown in Chinese consumption, or currency swings can move NHTC's results sharply. Smaller markets such as Taiwan, Peru and Korea have helped at the margin, but they are far too small to offset a decline in Greater China.

How might NHTC fit in a portfolio?

+

NHTC is a micro-cap with ~$5.8M of market value, thin trading and a concentrated, shrinking business, so it behaves very differently from a diversified fund or a large consumer staples stock. Investors who hold it generally do so as a net-cash special situation, where the thesis rests on the gap between the share price and the cash on the balance sheet, rather than as an income or growth holding. Position sizes in names like this are often kept small because price swings can be large and exiting can be slow. Walnut is not an investment adviser and this is not a recommendation; the Walnut assistant can show how a holding like NHTC affects your portfolio's concentration and performance.

Walnut is informational, not investment advice. Financial figures on this page are approximations; always verify current numbers with Natural Health Trends Corp.'s investor relations page or your broker before making investment decisions.